20 annual accounts with figures on one time axis, 33 filings since 1993
peak of €399,968 in 2025
€399,968▲ 22.9%
lowest -€37,415 in 2018
€148,100▲ 41.0%
peak of €416,182 in 2025
€416,182▲ 29.4%
€554,234▲ 14.8%
peak of 1.3 FTE in 2025
1.3 FTE▲ 30.0%
Board2 names since 2021
1 directorName after signing inVisible after signing in
Documentsfilings and deeds
03-06-202658 days before the deadline
2025abbreviated format
Gross margin from €325,370 to €399,968Result from €105,049 to €148,100Staff from 1 FTE to 1.3 FTEDividend €53,423Equity from €321,506 to €416,182Cash from €117,155 to €181,284
Four of the last ten came late. The 2019 accounts came in latest, 61 days after the end of the period.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 31,389 companies had the same profile as SYBEPHAR has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Micro
20 years or older
solvency 30% or more
a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,389 companies, not a prediction for SYBEPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0448892046
Name hiddenVisible after signing in resigns as director
Gazette deed
Hidden nameVisible after signing in (director) and Name after signing inVisible after signing in (director) change roles
“De uitbating van één of meer apotheken; De groot- en kleinhandel in,alsmede de bereiding van…” (deed in Dutch) · Gazette deed
Capital increase · Amendment of the articles
The capital rose from €49,578.70 to €144,474.82, with 3,828 new shares · The capital rose from €144,474.82 to €175,578.70 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as SYBEPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.1m, founded between 1991 and 1998.
The company number of SYBEPHAR is 0448.892.046. The VAT number is the same number with BE in front: BE 0448.892.046.
Where is SYBEPHAR based?
The registered office is at Beverestraat 50, 9700 Oudenaarde.Company details
What does SYBEPHAR do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of SYBEPHAR?
SYBEPHAR is a private limited company (BV).
When was SYBEPHAR founded?
SYBEPHAR was founded on 10-12-1992.
Is SYBEPHAR still active?
Yes, SYBEPHAR is an active enterprise in the KBO register.
How many employees does SYBEPHAR have?
SYBEPHAR had an average of 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does SYBEPHAR fall under?
In its 2025 annual accounts, SYBEPHAR states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of SYBEPHAR?
The turnover in financial year 2025 is ≈ €1.4m. This figure is estimated from the gross margin of €399,968 and 42 comparable companies (NACE 477). It probably lies between €1.1m and €1.9m.
Is SYBEPHAR profitable?
In financial year 2025, SYBEPHAR made a profit of €148,100.
Where can I find the annual accounts of SYBEPHAR?
SYBEPHAR filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SYBEPHAR due?
SYBEPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline